This study designed a methodology to evaluate the operations of the Clinical and Translational Science Awards (CTSA) consortium. The National Institutes of Health’s Roadmap for Medical Research Program launched the consortium to re-engineer the clinical research enterprise in the United States . This re-engineering was accomplished by transforming the local, regional and national environment for clinical and translational science, thereby increasing the efficiency and speed of clinical and translational research.
This feasibility study highlighted the complexity of the national CTSA initiative; and raised several overarching issues that need to be considered in the design and implementation of the prospective process evaluation study, including defining key terms, transitioning from the former General Clinical Research Center (GCRC) model to the CTSA model, capturing relevant contextual variables, and determining the critical timeframes for assessing the results of program activities and their outcomes.
Report Title: Clinical and Translational Science Awards Program: National CTSA Process Evaluation Feasibility Study; Report may be obtained from Federal Contact
Agency Sponsor: NIH, National Institutes of Health
Federal Contact: Patricia Newman, 301-435-0864
Performer: MasiMax Resources, Inc.
PIC ID: 9049